187 related articles for article (PubMed ID: 22956561)
1. Bayer challenges India's first compulsory licence for generic version of cancer drug.
Arie S
BMJ; 2012 Sep; 345():e6015. PubMed ID: 22956561
[No Abstract] [Full Text] [Related]
2. Indian health groups welcome country's first compulsory licence.
Mudur G
BMJ; 2012 Mar; 344():e2132. PubMed ID: 22427312
[No Abstract] [Full Text] [Related]
3. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
4. Intellectual property. Challenges to India's pharmaceutical patent laws.
Sampat BN; Shadlen KC; Amin TM
Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
[No Abstract] [Full Text] [Related]
5. India's new patent bill threatens generic industry.
Ahmad K
Lancet Infect Dis; 2005 May; 5(5):265. PubMed ID: 15889471
[No Abstract] [Full Text] [Related]
6. From outlier to trendsetter.
Bhaumik S; Biswas T
CMAJ; 2012 Sep; 184(12):E635-6. PubMed ID: 22826001
[No Abstract] [Full Text] [Related]
7. Africa could learn from India's burgeoning pharma sector.
Selvaraj S
BMJ; 2013 Aug; 347():f4235. PubMed ID: 23913693
[No Abstract] [Full Text] [Related]
8. India's patent case victory rattles Big Pharma.
Chatterjee P
Lancet; 2013 Apr; 381(9874):1263. PubMed ID: 23589911
[No Abstract] [Full Text] [Related]
9. Generic drug firm settles claim that it was paid to stay out of market.
Dyer O
BMJ; 2015 Apr; 350():h2282. PubMed ID: 25920419
[No Abstract] [Full Text] [Related]
10. The ongoing regulation of generic drugs.
Frank RG
N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956
[No Abstract] [Full Text] [Related]
11. Indian patients go to court over cancer drug.
Murdur G
BMJ; 2004 Aug; 329(7463):419. PubMed ID: 15321889
[No Abstract] [Full Text] [Related]
12. Is India ready to lead the battle for fair access to medicines?
Lancet Oncology
Lancet Oncol; 2013 May; 14(6):437. PubMed ID: 23639313
[No Abstract] [Full Text] [Related]
13. India's new patent laws may still hurt generic drug supplies.
Chatterjee P
Lancet; 2005 Apr 16-22; 365(9468):1378. PubMed ID: 15841559
[No Abstract] [Full Text] [Related]
14. Running short.
Mettner J
Minn Med; 2011 Oct; 94(10):8-10. PubMed ID: 23256277
[No Abstract] [Full Text] [Related]
15. Big Pharma vs India’s Patent Office.
Pharm Pat Anal; 2012 Nov; 1(5):529. PubMed ID: 24236921
[No Abstract] [Full Text] [Related]
16. AIDS drugs. Brazil, Thailand override big pharma patents.
Cohen J
Science; 2007 May; 316(5826):816. PubMed ID: 17495145
[No Abstract] [Full Text] [Related]
17. Generic drugs: the stalling game.
Consum Rep; 2001 Jul; 66(7):36-40. PubMed ID: 11725791
[TBL] [Abstract][Full Text] [Related]
18. India's rejection of Novartis's patent is but a small step in the right direction.
Bhaumik S
BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
[No Abstract] [Full Text] [Related]
19. Pharmaceuticals and medical devices: cost savings.
; Steiner DJ
Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
[No Abstract] [Full Text] [Related]
20. Pharmaceuticals and medical devices: cost savings. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-18. PubMed ID: 20213921
[No Abstract] [Full Text] [Related]
[Next] [New Search]
